Imugene Ltd News

Imugene Ltd: Proposed issue of securities - IMU

Dec 23, 2024 16:38 ET

Imugene Ltd: Notice of Extraordinary General Meeting/Proxy Form

Dec 23, 2024 02:25 ET

Imugene Ltd: Issuance of Convertible Notes & Warrants for up to $46m

Dec 23, 2024 01:29 ET

Imugene Ltd: Azer-cel Accepted for Presentation at ASTCT Tandem Meetings

Dec 19, 2024 21:20 ET

Imugene Ltd: Imugene Confirms Pending Receipt of c.$11m R&D Tax Refund

Dec 18, 2024 16:54 ET

Imugene Ltd: Updated Appendix 3Z

Nov 20, 2024 02:25 ET

Imugene Ltd: Final Director's Interest Notice

Nov 20, 2024 01:13 ET

Imugene Ltd: Director Resignation

Nov 14, 2024 16:23 ET

Imugene Ltd: Imugene 2024 AGM Results

Nov 13, 2024 21:59 ET

Imugene Ltd: Imugene AGM Presentation

Nov 13, 2024 16:24 ET

Imugene Ltd: onCARlytics Trial Doses First Patient in IT Combination Arm

Nov 10, 2024 17:03 ET

Imugene Ltd: Imugene Opens First Australian Site for azer-cel Trial

Nov 7, 2024 18:08 ET

Imugene Ltd: Complete Response in MAST Study Maintained Over Two Years

Nov 4, 2024 17:04 ET

Imugene Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Oct 30, 2024 18:10 ET

Imugene Ltd: Notification regarding unquoted securities - IMU

Oct 14, 2024 01:40 ET

Imugene Ltd: Notification of cessation of securities - IMU

Oct 14, 2024 01:37 ET

Imugene Ltd: Application for quotation of securities - IMU

Oct 14, 2024 01:36 ET

Imugene Ltd: Notice of Annual General Meeting/Proxy Form

Oct 14, 2024 01:28 ET

Imugene Ltd: Change of Director's Interest Notice - PH

Sep 30, 2024 03:01 ET

Imugene Ltd: Imugene Receives Orphan Drug Designation for VAXINIA

Sep 17, 2024 23:06 ET